Detection of early cardiac dysfunction in patients with beta thalassemia by tissue doppler echocardiography

Echocardiography

Volumn 28, Issue 2, 2011, Pages 175-180

  Marcí, Marcello ^a   Pitrolo, Lorella ^a   Lo Pinto, Carmela ^a   Sanfilippo, Nicola ^a   Malizia, Roberto ^a  

^a Azienda Ospedaliera   (Italy)

Author keywords

BNP; cardiomyopathy; echocardiography; heart failure; TDI; thalassemia major

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE;

ADULT; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; THALASSEMIA MAJOR; TISSUE DOPPLER IMAGING; VELOCITY;

ADULT; BETA-THALASSEMIA; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79551563323     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2010.01270.x     Document Type: Article

References (29)

1. Engle MA, Erlanson M, Smith CH,: Late cardiac complications of chronic, severe refractory anemia and hemochromatosis. Circulation 1964; 30: 698-705.
2. Olivieri NF, Nathan DG, MacMillan JH, et al,: Survival in medically treated patients with homozygous beta-thalassemia. NEJM 1994; 331: 574-8.
3. Borgna-Pignatti C, Rigolotto S, De Stefano P,: Survival and complications in patients with thalassemia major treated with transfusion and desferoxamine. Haematologica 2004; 89: 1187-1193.
4. Modell B, Khan M, Darlison M,: Survival in beta-thalassemia major in the UK: Data from the UK thalassemia register. Lancet 2000; 355: 2051-2052.
5. Cogliandro T, Derchi G, Mancuso L, et al,: Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med 2008; 9: 515-520.
6. Agricola E, Galderisi M, Opizzi M, et al,: Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart 2004; 90: 406-410.
7. Akpinar O, Acarturk E, Kanadasi M, et al,: Tissue Doppler imaging and NT-proBNP levels show the early impairment of ventricular function in patients with beta-thalassemia major. Acta Cardiol 2007; 62: 225-231.
8. Kremastinos DT, Tsiapras DP, Kostopoulou AG, et al,: NT-proBNP levels and diastolic dysfunction in beta-thalassemia major patients. Eur J Heart Fail 2007; 9: 531-536.
9. Aessopos A, Farmakis D, Polonifi A, et al,: Plasma B-type natriuretic pepide concentration in beta-thalassaemia patients. Eur. J. Heart Fail 2007; 9: 537-541.
10. Weyman AE,. Principles and practice of echocardiography. Philadelphia: Lea & Febiger, 1994.
11. Sahn DJ, De Maria A, Kisslo J, et al,: The committee on M-mode standardization of the American Society of Echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072.
12. Schiller NB, Shah PM, Crawford M,: Recommendations for quantization of the left ventricle by two-dimensional echocardiography. J Am soc Echocardiogr 1989; 2: 358.
13. Galderisi M, Nistri S, Ansalone G, et al,: Il Doppler tissutale pulsato illustrato ad uno specializzando in cardiologia. G Ital Cardiol 2007; 8: 92-102.
14. Amgastiniotis M, Modell B,: Global epidemiology of hemoglobin disorders. Ann NY Accad Sci 1998; 850: 251-259.
15. Cunningham MJ, Macklin EA, Neufeld EJ, et al,: Complication of β thalassemia major in North America. Blood 2004; 104: 34-39.
16. Borgna-Pignatti C, Rugolotto S, De stefano P, et al,: Survival and complications in talassemia. Ann NY Acad Sci 2005; 1054: 40-47.
17. Aessopos A, Berdoukas V, Tsironi M,: The heart in transfusion dependent homozygous thalassaemia today-prediction, prevention and management. Eur J Haematol 2008; 80: 93-106.
18. Vogel M, Anderson LJ, Holden S, et al,: Tissue Doppler echocardiography in patients with thalassemia detects early myocardial dysfunction related to myocardial iron overload. Eur Heart J 2003; 24: 113-11.
19. Tanner MA, Galanello R, Dessi C, et al,: A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007; 115: 1876-1884.
20. Huang YC, Chang JS, Wu KH, et al,: Regression of myocardial dysfunction after switching from desferrioxamine to deferiprone therapy in beta-thalassemia major patients. Hemoglobin 2006; 30: 229-238.
21. Chrysohoou C, Panagiotakos DB, Barbetseas Y, et al,: Echocardiographic and Electrocardiographic prognostic factors of heart failure in young patients with thalassemia major: A 10-Year (1995-2004) follow-up. Int J Hematol 2004; 80: 336-340.
22. Kremastinos D, Tsiapra DP, Tsetsos GA, et al,: Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation 1993; 88: 1127-1135.
23. Katritsis D, Wilmshurst PT, Wnedon JA, et al,: Primary restrictive cardiomyopathy: Clinical characteristics and pathological findings. JACC 1992; 18: 1230-1235.
24. Nagueh SF, Middleton KJ, Kopelen HA, et al,: Doppler tissue imaging: A non invasive technique for evaluation of left ventricular relaxation and estimation of filling pressure. J Am Coll Cardiol 1997; 30: 1527-1533.
25. Hamdy AM,: Use of strain and tissue velocity imaging for early detection ofregional myocardial dysfunction in patients with beta thalassemia. Eur J Echocardiography 2007; 8: 102-109.
26. Hamdy AM, Zein El-Abdin MY, Abdel-Hafey MA,: Tissue Doppler has an important prognostic value in patients with beta thalassemia. Echocardiography 2008; 25: 554-555.
27. Tang WH, Francis GS, Morrow DA, et al,: National academy of clinical biochemistry laboratory medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007; 116: e99-e109.
28. Packer M,: Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 2003; 108: 2950-2953.
29. Tang WH, Girod JP, Lee MJ, et al,: Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003; 108: 2964-2966.